-
I659429-100mgαvβ1 integrin-IN-1 TFA (Compound C8) is a potent and selective αvβ1 integrin inhibitor with an IC 50 of 0.63 nM. Antifibrotic effects.Appearance:SolidIC50& Target:IC50: 0.63 nM (αvβ1 integrin)In Vitro:αvβ1 integrin-IN-1 TFA (Compound C8)
-
I659429-10mgαvβ1 integrin-IN-1 TFA (Compound C8) is a potent and selective αvβ1 integrin inhibitor with an IC 50 of 0.63 nM. Antifibrotic effects.Appearance:SolidIC50& Target:IC50: 0.63 nM (αvβ1 integrin)In Vitro:αvβ1 integrin-IN-1 TFA (Compound C8)
-
I659429-50mgαvβ1 integrin-IN-1 TFA (Compound C8) is a potent and selective αvβ1 integrin inhibitor with an IC 50 of 0.63 nM. Antifibrotic effects.Appearance:SolidIC50& Target:IC50: 0.63 nM (αvβ1 integrin)In Vitro:αvβ1 integrin-IN-1 TFA (Compound C8)
-
I659429-5mgαvβ1 integrin-IN-1 TFA (Compound C8) is a potent and selective αvβ1 integrin inhibitor with an IC 50 of 0.63 nM. Antifibrotic effects.Appearance:SolidIC50& Target:IC50: 0.63 nM (αvβ1 integrin)In Vitro:αvβ1 integrin-IN-1 TFA (Compound C8)
-
I661703-1mlαvβ1 integrin-IN-1 TFA (Compound C8) is a potent and selective αvβ1 integrin inhibitor with an IC 50 of 0.63 nM. Antifibrotic effects.IC50& Target:IC50: 0.63 nM (αvβ1 integrin)In Vitro:αvβ1 integrin-IN-1 TFA (Compound C8) significantly reduces
-
I650350-10mgαvβ5 integrin-IN-1 is a first potent and selective αvβ5 integrin inhibitor (p IC 50 = 8.2) .Form:Solid
-
I650350-5mgαvβ5 integrin-IN-1 is a first potent and selective αvβ5 integrin inhibitor (p IC 50 = 8.2) .Form:Solid